PharmaTimes’ Editor John Pinching talks to AstraZeneca’s inspiring diversity and inclusion leader for Europe and Canada, Anna-Lena Engwall
Why is it important for pharma and wider healthcare to embrace and celebrate diversity and inclusion?
Inclusion and diversity is not only the right thing to do, but it is essential for companies like AstraZeneca – companies that have a science-led mission. It is well known that diverse teams drive higher levels of innovation and increased performance, while better representing the broad patient populations we serve.
Innovation will be integral to the reinvention of healthcare. Health systems need to evolve, become more sustainable and resilient to meet the needs of the future. For our industry, which is part of the wider healthcare system, it is essential that we promote diversity in the backgrounds, beliefs, perspectives and experiences of our workforce.
Check out the rest of this feature here